Megalencephalic leukodystrophy with subcortical cysts is a type of demyelinating leukodystrophy caused by mutations in MLC1 gene. Studies in MLC are scare and the few published are limited in either sample size or methods of molecular diagnosis In silico analysis of SNPs in a well-known disease causing gene is a valuable method of analyzing known variants deposited in public databases. This article aimed to analyze all SNPs in MLC1 gene in order to determine probable disease causing variants that are not yet been evaluated SNPs in MLC1 gene were retrieved from NCBI dbSNP. Variants in VCF format were analyzed using Variant Effect Predictor [VEP] of the Ensembl database. The deleterious coding ns SNPs were evaluated by the web programs SIFT, PolyPhen and Mutation Taster in addition to allele frequency and conservation score. Structural analysis was performed in order to evaluate and compare the stability of native and mutant structures. The effect of amino acid changes on the stability of MLC protein was evaluated using I-Mutant 2.0 web server. In MLC1 gene, 4 analyzed SNPs resulted nonsense, 18 are indels [frame shift mutations] and 10 potentially disrupt splicing. Six variants in MLC1 gene were predicted to be pathogenic. The results of our study will facilitate future studies aimed to analyze the genetics of MLC in different families from different populations.
INTRODUCTION
Leukodystrophies are group of inherited disorders caused primarily by defective myelination of the central nervous system with or without peripheral nervous system involvement [1] . Over 30 types of leukodystrophy disorders have been described with various age of onset and clinical presentation but they all share white matter signals in brain MRI [2] . Individual leukodystrophy types are rare -although they vary depending on the populationbut collectively they are not uncommon [3] .
Megalencephalic leukodystrophy with subcortical cysts is a type of leukodystrophy caused by mutations in MLC1 gene and less commonly in HEPACAM gene [4] . The disease presents with early in life head enlargement, motor dysfunction and occasionally epilepsy. All kinds of mutations in MLC1 gene were described [4] . However, studies in MLC are scare and the few published are limited in either sample size or methods for molecular diagnosis [5] .
In silico analysis of SNPs in a well-known disease causing gene is an efficient way of screening known variants deposited in public databases to determine probable disease causing variants that are not yet evaluated. This approach has been proven valuable in many situations [6] [7] [8] [9] and this is more important for rarely studied disease like MLC. Results of such in silico analyses can be used to screen patients with MLC using, for example, SNP microarray. This article aimed to analyze all SNPs in MLC1 gene in order to determine potential variants causing MLC that are not yet been evaluated as possible pathogenetic.
MATERIALS AND METHODS
The SNPs in MLC1 gene were retrieved from NCBI dbSNP database [https://www.ncbi.nlm.nih.gov/projects/SNP/]. Frame shift, nonsense and splicing variants were identified. Non-synonymous missense variants were analyzed using web programs SIFT, Poly Phen and Mutation Taster using Variant Effect Predictor [VEP] of the Ensembl database http://www. ensembl.org/Tools/VEP. Predicted pathogenic variants were filtered as follows: SIFT score < 0.05, PolyPhen score > 0.85 and Allele frequency < 0.05. Pathogenicity of variants were verified using amino acid conservation from Alamut visual http://www. interactive-biosoftware.com/doc/alamut-visual/2.9/ Structural analysis was performed in order to evaluate and compare the stability of native and mutant structures. The effect of amino acid changes on the stability of MLC protein was evaluated using I-Mutant 2.0 web server [10] .
RESULTS
The MLC1 gene contains 1471 SNPs, the majority of which were intrinsic [44%] and upstream variants [22%]. Coding variants were most commonly missense [62%] and synonymous [30%], (Figure 1 ).
DISCUSSION
In silico analysis of SNPs in disease causing genes with unknown clinical significance and deposited in public databases is a valuable method screen patients with the respective disease using for example SNP microarray. This study aimed to determine potential disease causing variants in MLC1 gene using in silico prediction methods. The result showed that potential disease causing variants in MLC1 gene are most commonly indels causing frame shift mutations. This is in accordance with the molecular pathogenesis of the disease which is consequent to a loss of function of MLC protein. Frame shifting mutations are known to disrupt protein synthesis and impair protein's function [11] . Frame shifting mutations were indeed found in many studies underlying this form of leukodystrophy [12] [13] [14] [15] . Variants causing disruption of splicing lead to either retention of an intron or loss of an exon and nonsense variants cause premature termination of protein synthesis. Both nonsense and splicing variants are loss of function mutations [16] . Nonsense variants causing MLC were previously reported [17] [18] [19] and so were splicing defects [15, 20] .
Missense variants causing MLC1 have been reported before [21] . Judging from the in silico prediction methods which include conservation, allele frequency and tolerance of amino acid changes, the variants reported in our study are very likely to be pathogenic, but they are all novel and their association with MLC is yet to be confirmed. A limit of our study is that neither biological modeling nor segregation in family studies, the only accepted way to evaluate a variant as pathogenic, have been performed. MLC is an autosomal recessive disease and this explains why these variants were not found in a homozygous state in any of the studied populations in the exact database.
Our results will facilitate future epidemiological studies aimed to analyze the genetics of MLC in different families from different populations. Moreover they can have a role in genetic counseling, in particular for an alleged determination of frequency of heterozygote individuals in specific populations and, therefore, of the risk of a known mutation carrier to find a MLC mutation carrying partner. The results of in silico predictive studies, nonetheless the limitation of determine only potential and not validate predictions, will also accelerate variants annotation keeping in advancing genome and exome studies. Probably damaging (0.994) Disease causing 0.0004 High *AA = Amino acid change **AF = Allele frequency Three of these mutations (A208V, N218K and V260L) lie in the trans-membrane domain of MLC1 protein (not shown). All potentially pathogenic amino acid changes in our studies (in Table 2 ) were predicted to significantly decrease the stability of MLC protein using I-Mutant 2.0 web server.
